%0 Journal Article
%T Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US
%A Christopher M Blanchette
%A Emily Zacherle
%A Jeffrey T Guptill
%A Joshua M Noone
%A M Chris Runken
%A Michael Eaddy
%A Orsolya E Lunacsek
%A Rupali M Fuldeore
%J Archive of "Patient preference and adherence".
%D 2019
%R 10.2147/PPA.S185852
%X Purpose: For chronic inflammatory demyelinating polyneuropathy (CIDP) patients, each branded intravenous immunoglobulin (IVIG) treatment differs in production processes, virus elimination, formulation, and composition. Given the limited availability of real-world data comparing IVIGs for CIDP, this study evaluated switching patterns between IVIG products in 2 separate retrospective databases
%K intravenous immunoglobulin
%K chronic inflammatory demyelinating polyneuropathy
%K treatment patterns
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503323/